202 related articles for article (PubMed ID: 18725859)
1. Cost-effectiveness of hearing aids in the hearing-impaired elderly: a probabilistic approach.
Chao TK; Chen TH
Otol Neurotol; 2008 Sep; 29(6):776-83. PubMed ID: 18725859
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of salmeterol, fluticasone, and combination therapy for COPD.
Oba Y
Am J Manag Care; 2009 Apr; 15(4):226-32. PubMed ID: 19355795
[TBL] [Abstract][Full Text] [Related]
3. Plant stanol esters are potentially cost-effective in the prevention of coronary heart disease in men: Bayesian modelling approach.
Martikainen JA; Ottelin AM; Kiviniemi V; Gylling H
Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):265-72. PubMed ID: 17446806
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.
Greving JP; Buskens E; Koffijberg H; Algra A
Circulation; 2008 Jun; 117(22):2875-83. PubMed ID: 18506010
[TBL] [Abstract][Full Text] [Related]
5. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura.
Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride JE; Pi D; Goeree R
Clin Ther; 2009 May; 31(5):1082-91; discussion 1066-8. PubMed ID: 19539109
[TBL] [Abstract][Full Text] [Related]
6. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
[TBL] [Abstract][Full Text] [Related]
7. Illustrating economic evaluation of diagnostic technologies: comparing Helicobacter pylori screening strategies in prevention of gastric cancer in Canada.
Xie F; O'Reilly D; Ferrusi IL; Blackhouse G; Bowen JM; Tarride JE; Goeree R
J Am Coll Radiol; 2009 May; 6(5):317-23. PubMed ID: 19394572
[TBL] [Abstract][Full Text] [Related]
8. Estimated cost-effectiveness of active middle-ear implantation in hearing-impaired patients with severe external otitis.
Snik AF; van Duijnhoven NT; Mylanus EA; Cremers CW
Arch Otolaryngol Head Neck Surg; 2006 Nov; 132(11):1210-5. PubMed ID: 17116816
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of botulinum toxin a versus anticholinergic medications for idiopathic urge incontinence.
Wu JM; Siddiqui NY; Amundsen CL; Myers ER; Havrilesky LJ; Visco AG
J Urol; 2009 May; 181(5):2181-6. PubMed ID: 19296983
[TBL] [Abstract][Full Text] [Related]
10. Dynamic modeling in medical technology assessment. Fitting hearing aids in The Netherlands.
Boas G; van der Stel H; Peters H; Joore M; Anteunis L
Int J Technol Assess Health Care; 2001; 17(4):618-25. PubMed ID: 11758306
[TBL] [Abstract][Full Text] [Related]
11. Outcome measurement for patients receiving hearing aid services.
Cook JA; Hawkins DB
Laryngoscope; 2007 Apr; 117(4):610-3. PubMed ID: 17415130
[TBL] [Abstract][Full Text] [Related]
12. The effect of the base line response on self-adjustments of hearing aid gain.
Keidser G; Dillon H; Convery E
J Acoust Soc Am; 2008 Sep; 124(3):1668-81. PubMed ID: 19045657
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of acupuncture in women and men with allergic rhinitis: a randomized controlled study in usual care.
Witt CM; Reinhold T; Jena S; Brinkhaus B; Willich SN
Am J Epidemiol; 2009 Mar; 169(5):562-71. PubMed ID: 19126587
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of recombinant follicle-stimulating hormone (FSH) versus human FSH in intrauterine insemination cycles: a statistical model-derived analysis.
Gerli S; Bini V; Di Renzo GC
Gynecol Endocrinol; 2008 Jan; 24(1):18-23. PubMed ID: 18224540
[TBL] [Abstract][Full Text] [Related]
15. Asymptomatic pancreatic cystic neoplasm: a cost-effectiveness analysis of different strategies of management.
Das A; Ngamruengphong S; Nagendra S; Chak A
Gastrointest Endosc; 2009 Oct; 70(4):690-699.e6. PubMed ID: 19647240
[TBL] [Abstract][Full Text] [Related]
16. A Markov model assessing the effectiveness and cost-effectiveness of FOLFOX compared with FOLFIRI for the initial treatment of metastatic colorectal cancer.
Tumeh JW; Shenoy PJ; Moore SG; Kauh J; Flowers C
Am J Clin Oncol; 2009 Feb; 32(1):49-55. PubMed ID: 19194125
[TBL] [Abstract][Full Text] [Related]
17. Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness.
Desai K; Sansom SL; Ackers ML; Stewart SR; Hall HI; Hu DJ; Sanders R; Scotton CR; Soorapanth S; Boily MC; Garnett GP; McElroy PD
AIDS; 2008 Sep; 22(14):1829-39. PubMed ID: 18753932
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of linezolid vs. vancomycin in treating methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infections using a decision analytic model.
Bounthavong M; Hsu DI; Okamoto MP
Int J Clin Pract; 2009 Mar; 63(3):376-86. PubMed ID: 19222624
[TBL] [Abstract][Full Text] [Related]
19. The factors associated with a self-perceived hearing handicap in elderly people with hearing impairment--results from a community-based study.
Chang HP; Ho CY; Chou P
Ear Hear; 2009 Oct; 30(5):576-83. PubMed ID: 19633566
[TBL] [Abstract][Full Text] [Related]
20. The relationship between pre-fitting expectations and willingness to use hearing aids.
Meister H; Walger M; Brehmer D; von Wedel UC; von Wedel H
Int J Audiol; 2008 Apr; 47(4):153-9. PubMed ID: 18389410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
